Loading…
Augmentation of Sodium Butyrate-induced Apoptosis by Phosphatidylinositol 3-kinase Inhibition in the Human Cervical Cancer Cell-line
Purpose: Sodium butyrate (NaBT) is principally a histone deacetylase (HDAC) inhibitor, and it has the potential to arrest HPV-positive carcinoma cells at the G1 to S phase transition of the cell cycle. The aim of study was to determine whether phosphatidylinositol 3-kinase (PI3K) inhibition can enha...
Saved in:
Published in: | Cancer research and treatment 2006, 38(2), , pp.112-117 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | Korean |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose: Sodium butyrate (NaBT) is principally a histone
deacetylase (HDAC) inhibitor, and it has the potential
to arrest HPV-positive carcinoma cells at the G1 to
S phase transition of the cell cycle. The aim of study was
to determine whether phosphatidylinositol 3-kinase
(PI3K) inhibition can enhance the inhibitory effect of
NaBT on a human cervical cancer cell line (HeLa).
Materials and Methods: Cervical cancer cells (HeLa)
were treated with NaBT alone or in combination with the
PI3K inhibitors wortmannin or LY294002. Cell viability
analysis and FACS analysis were carried out. The expressions
of the cell cycle related proteins were evaluated
by Western-blot analysis.
Results: Inhibition of PI3K enhanced NaBT-mediated
apoptosis and this decreased the HeLa cell viability.
Either wortmannin or LY294002, combined with NaBT,
enhanced the activation of caspase 3 and caspase 9, and
this enhanced the subsequent cleavage of poly (ADPribose)
polymerase (PARP). Cervical cancer cells were
arrested in the subG1 and G2/M phase, as was detected
by FACS analysis. NaBT treatment in combination with
PI3K inhibitors showed the increased expression of the
CDK inhibitors p21Cip1/Waf1 and p27Kip1, in a p53 dependent
manner, and also the increased dephosphorylation of Rb
whereas there was a reduction in the expression levels
of cyclin A, cyclin D1 and cyclin B1.
Conclusion: The results demonstrate that inhibition of
PI3K enhances NaBT-mediated cervical cancer cell apoptosis
through the activation of the caspase pathway.
Moreover, these findings will support future investigation
using the PI3K inhibitors in combination with adjuvant
treatment for treating carcinoma of the cervix. (Cancer
Res Treat. 2006;38:112-117) KCI Citation Count: 0 |
---|---|
ISSN: | 1598-2998 2005-9256 |